Cargando…

OR14-1 Pharmacodynamics, Safety, Tolerability, and Efficacy of Oral Insulin Formulation (Oshadi Icp) among Young Adults with Type 1 Diabetes: A Summary of Clinical Studies Phases I, Ib, and Ii

Background Replacement of subcutaneous (SC) insulin by oral insulin for Type I diabetes (T1D) could promote patient compliance and minimize hyperinsulinemia. Oshadi Drug Administration Ltd. has developed an oral carrier for proteins delivery, composed of known ingredients, including polysaccharides...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rachmiel, Marianna, Barash, Galia, Leshem, Avital, Sagi, Roy, doenyas-barak, Keren, Koren, Shlomit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554863/ http://dx.doi.org/10.1210/js.2019-OR14-1

Ejemplares similares

Glycaemic Control in Children and Adolescents With Type 1 Diabetes Following a Single Telehealth Visit:What Have We Learned From the COVID-19 Lockdown?
por: Rachmiel, Marianna, et al.
Publicado: (2021)

Novel Perspectives of Super-High Dose Glybenclamide in an Infant With DEND Syndrome
por: Barash, Galia, et al.
Publicado: (2021)

MON-659 Course of Puberty and Growth Spurt in Boys with Type 1 Diabetes
por: Shpitzer, Hana, et al.
Publicado: (2020)

SAT-171 Effective Intrajejunal Wall Delivery of Recombinant Human Insulin via a Self-Deployed Ingestible Capsule in Anesthetized Swines: A Pharmacokinetic and Pharmacodynamic Study
por: Hashim, Mir, et al.
Publicado: (2019)

SAT-674 Anti PD1 Induced Type 1 Diabetes
por: Naranjo, Maria Belen, et al.
Publicado: (2020)

SAT-150 Forkhead Box Protein O1 (foxo1) Regulates Hepatic Serine Protease Inhibitor B1 (serpinb1) Expression In A Cell Non-autonomous Fashion
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2019)

SUN-128 Novel Mutation in the HNF1A Gene in Siblings Previously Diagnosed with Type 1 Diabetes
por: Raisingani, Manish, et al.
Publicado: (2019)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

SAT-680 Diabetes Mellitus Induced by Programmed Cell Death-1 (PD-1) Inhibitors: A Case Report
por: Abuaisha, Munder, et al.
Publicado: (2020)

MON-625 Utility of Continuous Glucose Monitoring in Children with Type 1 Diabetes: Is HbA1c Enough?
por: Owens, Lindsey L, et al.
Publicado: (2020)

Young Adult LEW.1WR1 Rats Develop Dysregulated Islet Function and Impaired Liver Insulin Responses
por: Wilkerson-Vidal, Quiana C, et al.
Publicado: (2021)

OR14-3 The Association of Glycemic Control and Glycemic Variability with Treatment Patterns and Diabetes-Related Events in the Adult Patients (Pts) with Type 1 Diabetes (T1D): Results from the T1D Exchange Clinic Registry
por: Wysham, Carol, et al.
Publicado: (2019)

SAT-668 Liver Function Test in Type 1 Diabetes Mellitus and Prevalence of Other Autoimmune Disease in Type 1 Diabetes Mellitus
por: Anusha, Nadig, et al.
Publicado: (2020)

SUN-646 A Novel Population of FOXO1-Expressing Cells in the Stomach Controls Cell Plasticity by Regulating the Cyclin CCNE1
por: McKimpson, Wendy M, et al.
Publicado: (2020)

OR28-1 Role of Mineralocorticoid Receptor in Metabolic Syndrome
por: Ferguson, Daniel, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor Associated Type 1 Diabetes
por: Duenas, Jose Andres, et al.
Publicado: (2021)

MON-130 Optimal Glycemic Control in a Patient with HNF1A MODY with GLP1-RA Monotherapy: Implications for Future Therapy
por: Fantasia, Kathryn, et al.
Publicado: (2019)

SAT-153 Role Of Increased Serum- And Glucocorticoid-inducible Kinase 1 (SGK1) Activity In Gluconeogenesis And Liver Metabolism During Metabolic Syndrome.
por: Velazquez-Garcia, Silvia, et al.
Publicado: (2019)

Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Children With Type 1 Diabetes (T1D)
por: Buckingham, Bruce A, et al.
Publicado: (2021)

SUN-LB027 Successful Transition from Insulin Injections to Oral Sufonylurea Therapy in Children with Non Autoimmune Type 1 Diabetes (T1D)
por: Begum-Hasan, Jahanara
Publicado: (2019)

SAT-LB032 Young Adult LEW.1WR1 Rats Develop Increased Glucose Intolerance on a Moderately Increased Sucrose Diet
por: Collins, Genoah, et al.
Publicado: (2019)

SAT-126 The Relationship of Continuous Glucose Monitoring (CGM)-Derived Time-in-Range (TIR) to Hemoglobin A1c (HbA1c)
por: Vigersky, Robert, et al.
Publicado: (2019)

MON-126 Fulminant Type 1 Diabetes Caused by "Jumping"
por: Chen, Yaning, et al.
Publicado: (2019)

An Unusual Form of Type 1 Diabetes With an Elevated Proinsulin Level
por: Havranova, Jana, et al.
Publicado: (2021)

Psychological Impact of Diabetes Technology on Type 1 Diabetes Pregnancy
por: Less, Jacob, et al.
Publicado: (2021)

SAT-662 Effects of SGLT Inhibitors or GLP1 Analogues on Glucose Homeostasis and Body Weight in Patients with Type 1 Diabetes: A Network Meta-Analysis
por: Lim, Soo, et al.
Publicado: (2020)

MON-613 The Expression of TBC1 Domain Family, Member 4 (TBC1D4) in Skeletal Muscles of Insulin-Resistant Mice in Response to Sulforaphane
por: Rizk, Nasser M, et al.
Publicado: (2020)

SAT-LB025 Analysis of Benefit/Risk in the Subgroup of Patients with BMI of >=27 Kg/m(2) in the Dapagliflozin DEPICT-1 and -2 Trials in Type 1 Diabetes
por: Mathieu, Chantal, et al.
Publicado: (2019)

A Phase 2 Evaluation of a Novel Co-Formulation of Pramlintide and Regular Insulin to Improve Postprandial Glycemic Control in Adults with Type 1 Diabetes (T1D)
por: Edelman, Steven Victor, et al.
Publicado: (2021)

MON-123 Atypical Diabetes Mellitus or Type 1 Diabetes Mellitus?
por: Havrylyan, Andriy, et al.
Publicado: (2019)

SAT-677 A Case of Opdivo Induced Type 1 Diabetes
por: Lucier, Jessica, et al.
Publicado: (2020)

OR26-05 The Correction Factor for A1C in Anemic Patients
por: Villacreses, Maria Chang, et al.
Publicado: (2020)

The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx
por: Lozada Orquera, Faustina Alejandra, et al.
Publicado: (2021)

Covid Lockdown Impact on Type 1 Diabetes Health and Well-Being
por: Calma, Jamie, et al.
Publicado: (2021)

MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects
por: Faustman, Denise, et al.
Publicado: (2019)

OR30-01 Real-World Minimed™ 670G System Use and Glycemic Outcomes of Pediatric and Adult Individuals Living with Type 1 Diabetes (T1D) in the United States
por: Vigersky, Robert Alan, et al.
Publicado: (2020)

Impact of COVID 19 National Lockdown on Glycaemic Control in Children and Adolescents With Type 1 Diabetes (T1DM): A Retrospective Review at a Large UK Teaching Hospital
por: Lawrence, Neil Richard, et al.
Publicado: (2021)

SAT-164 Cornus Officinalis Significantly Improves Oxidative Capacity and Promotes the Calcium-Dependent Transcription Factor, NFATC2, in Human 1.1B4 Pancreatic Cell Line
por: Sharp, Arielle, et al.
Publicado: (2019)

MON-125 Can a Lupus Flare Cause Type 1 Diabetes?
por: Havrylyan, Andriy, et al.
Publicado: (2019)

SAT-174 Loss of CEACAM1 in Endothelial Cells Causes Hepatic Fibrogenesis
por: Muturi, Harrison, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vsjpg3pdm9lb2jr4jhgjlv49lu